# Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)

> **NCT00650819** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 240 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Ezetimibe + Simvastatin
- **DRUG:** Simvastatin
- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT00650819
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06-01
- **Primary completion:** 2005-02-01
- **Final completion:** 2005-02-01
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00650819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00650819, "Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00650819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*